The goal of the study is to validate a biomarker assay for unipolar depression based on serum proteins involved in inflammation, metabolism, and stress response. The study will compare patients with a current major depressive episode to individuals with no history of depression. The hypothesis is that the assay can serve as a diagnostic tool that would be more objective than standard diagnostic questionnaires.
Study Type
OBSERVATIONAL
Enrollment
160
Steward St. Elizabeth's Medical Center
Boston, Massachusetts, United States
Protein biomarker MDDScore.
Time frame: 0 weeks
Score on Hamilton Depression Rating Scale (HDRS).
Time frame: 0 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.